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Background: Obstructive sleep apnea syndrome is associated with airway inflammation. Mea-
surement of exhaled nitric oxide is a non-invasive method for evaluation of airway diseases.
It seems that obesity is an exacerbating factor for airway inflammation. We aimed to evaluate
the changes of exhaled nitric oxide after sleep in patients suffering from OSA regarding BMI.
Method: In 54 patients referred for polysomnography, exhaled nitric oxide measurements were
performed before and after sleep. Subjects were divided into three categories: normal, obese
with sleep apnea and non-obese, based on polysomnographic recordings and BMI.
Results: 47 subjects had abnormal apnea/hypopnea index (AHI mean Z 39.7) and 7 were
normal regarding AHI (AHI meanZ 3.0). BMI was significantly correlated to AHI, number of de-
saturations and hypoxia. Among those with apnea, 31 subjects were obese and 16 were non-
obese. Exhaled nitric oxide levels in normal and OSA subjects showed no significant change,
but a significant increase was found in obese patients with apnea (14.7 pre-sleep mean,
20.0 post-sleep mean).
Conclusions: Obesity is an effective factor in the inflammation of airways in patients with
obstructive apnea.
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Obstructive sleep apnea (OSA) syndrome is characterized
by an incomplete or complete and intermittent airflow
obstruction during sleep which is associated with respira-
tory effort. The obstruction is usually associated with
upper airway obstruction and causes such complaints as
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tient’s bed partner. This sleep is not refreshing and may
lead to daytime sleepiness [1]. OSA is a risk factor for
cardiovascular disorders and is associated with increased
morbidity and mortality [2]. Periods of decreased oxygen
saturation in OSA patients leads to oxidative stress and free
radical formation and release of inflammatory mediators
[3]. This inflammation and oxidative stress can be detected
and monitored using non-invasive methods such as induced
sputum, exhaled breath condensate and exhaled gases.
One of the first exhaled gases used for the evaluation of
patients with apnea was nitric oxide. The non-invasive
technique of fractional exhaled NO (FENO) makes it an
ideal test for evaluation of patients with upper airway
diseases [4].
By now there are few studies with controversial results
for the evaluation of this index among patients with apnea.
One of the first studies in this regard was conducted by
Olopade et al. which showed a significant increase in NO
after sleep among patients with apnea [5], but Agusti et al.
didn’t find a significant difference between patients with
apnea and normal subjects in terms of NO concentration
[6]. The prevalence of OSA in general population is 4% in
men and 2% in middle-aged women [7], which reaches to
20%e40% in individuals with body mass index (BMI) higher
than 30 kg/m2 [8]. Although the relationship between
obesity and systemic inflammation is obviously known
[9e11], the relationship between obesity and airway
inflammation has not been clearly understood among pa-
tients suffering from OSA.
In this study we aimed to evaluate the changes of
exhaled nitric oxide after sleep in patients suffering from
OSA regarding BMI.
Materials and methods
Study subjects
Study subjects included 54 patients referred to sleep clinic
of Shahid Sadoughi University of Medical Sciences for night-
time polysomnography. Exclusion criteria included severe
respiratory infection in the last 6 weeks, treatment with
oral or inhalational corticosteroids, consuming drugs
releasing nitric oxide in the body (e.g. isosorbide dinitrate)
and using leukotriene modifiers (e.g. zafirlukast) and ciga-
rette smokers (those who smoked at least 0.5 pack-years
were considered as smokers, but ex-smokers were included
in the study if they have quitted smoking more than 1 year
ago).
Study design
This was a cross-sectional study on patients referring to
sleep clinic of Shahid Sadoughi University of medical sci-
ences for night-time polysomnography. Neck and abdominal
circumferences were measured by a tape meter. Height
was measured using a stadiometer to the nearest 0.5 cm.
Weight was measured by a digital weight scale (Laica, Italy,
accuracy: 100 g). BMI was calculated by dividing weight in
kilograms by the square height in meters. Subjects were
divided into two groups based on their BMI: BMI 30 asobese and BMI <30 as non-obese. The study was approved
by ethics committee of Shahid Sadoughi University of
Medical Sciences. An informed consent was obtained from
all participants.FENO measurement
FENO was measured before and after night-time poly-
somnography (10 PM, and 6 AM) by a portable
electrochemistry-based device (NObreath, Bedfont Sci-
entific Ltd., UK). All tests were performed according to
American Thoracic Society/European Respiratory Society
(ATS/ERS) guidelines [12]. Results were reported in part
per billion (ppb). Subjects were asked to perform expira-
tion for 10 s with a constant flow (50 ml/s) and pressure
(10 CmH2O) in a sitting position. Measurements were
repeated until we obtained at least two acceptable ma-
neuvers with FENO differences less than 4 ppb. The mean
of two tests was reported as the final result. The mea-
surements were repeated after work shift (8 h). The sub-
jects were asked to avoid heavy exercise such as stair
climbing and heavy lifting, large meals and smoking (for
recreational smokers with less than 0.5 pack-year of
smoking) one hour before test.Lung function assessment
Spirometry was performed with spirolab III device (MIR,
Italy). Forced vital capacity (FVC), forced expiratory vol-
ume after 1 s (FEV1), peak expiratory flow (PEF), and forced
expiratory flow between 25% and 75% of FVC (FEF25e75%)
were measured according to ATS/ERS guidelines [13]. All
tests were performed under standardized conditions at
body temperature and ambient pressure saturated with
water vapor, with the subject in a sitting position and using
a nose clip. All subjects performed spirometry under similar
conditions. The highest of three technically acceptable
recordings was used.Polysomnography
Night-time polysomnography was performed for all sub-
jects (device: SOMNOscreen plus TM PSG, SOMNOmedics,
Germany). Sleep stages were defined using electroen-
cephalograms (channels: C4-A2 and O2-A1), electrooculo-
grams, and chin electromyogram. Respiratory events were
detected by a thermistor and a nasal prong. Respiratory
movements were detected by thoracic and abdominal
bands. O2 saturation was assessed by a pulse-oximeter. The
test was scored by an occupational medicine specialist
blinded to the study according to American Academy of
Sleep Medicine Manual for the Scoring of Sleep and Asso-
ciated Events [14]. Apnea/hypopnea index (AHI) <5 was
considered normal, and those with AHI 5 with obstructive
and mixed apneas were considered as cases of obstructive
sleep apnea syndrome (OSA). Hypoxia was defined as O2
saturation <90%. Total time of hypoxia and number of
desaturations during sleep were also measured.
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Data analysis was done using Windows IBM SPSS Statistics
version 19 (IBM Corp., North Castle, NY). Quantitative data
were expressed by mean  standard deviation (SD) for
normally distributed and mean (10e90 percentiles) for non-
parametric ones. KolmogoroveSmirnov test was used to
test normality of data. Polysomnographic and exhaled nitric
oxide data were not normally distributed. Student’s t-test
and non-parametric tests including Wilcoxon signed-rank
and ManneWhiney U tests were used for analysis of data.
Correlation between parameters was tested by Pearson’s
and Spearman correlation tests. Level of significance was
set at P < 0.05.Results
Anthropometry and spirometry
Among all subjects, 42 were males and 12 were females.
Among those with OSA, 31 subjects (66%) were obese and 16
(34%) were non-obese. There was one ex-smoker and one
recreational smoker. Mean anthropometric measurements
were significantly different between obese and non-obese
subjects (P < 0.001). Mean spirometric parameters were
not significantly different between two groups. Among
spirometric parameters only FVC was significantly corre-
lated with BMI (P Z 0.018, r Z 0.423). Table 1 shows
anthropometric and spirometric parameters in the study
population.Polysomnography
According to the results of polysomnography, 47 subjects
(87%) had abnormal AHI (OSA). Mean AHI in the normal and
OSA subjects was 3.0 (1.4e4.9) and 39.7 (8.1e70.7) events
per hour, respectively. BMI was significantly correlated to
AHI (r Z 0.45, P Z 0.001), number of desaturations
(rZ 0.47, P < 0.001) and hypoxia (rZ 0.46, P < 0.001). We
found a significant correlation between neck circumference
and abdominal circumference and AHI (r Z 0.40,
PZ 0.002; and rZ 0.36, PZ 0.008, respectively). Table 2Table 1 Anthropometric and spirometric parameters of study p
Variable Normal
n Z 7
Age, years 44.8  7.4
BMI, kg m2 26.1  4.4
Neck circumference, Cm 38.7  5.5
Abdominal circumference, Cm 99.4  9.2
FVC, L 3.7  1.6
FEV1, L 2.9  1.2
FEV1/FVC, % 79.9  6.0
FEF25%e75%, L/s 2.8  1.1
Data are presented as mean  SD.
a P < 0.05 vs obese patients.shows the results of polysomnography and exhaled nitric
oxide measurements.
Exhaled nitric oxide
Mean exhaled nitric oxide in study population before and
after sleep was 15.7 (3.0e33.5) ppb and 18.9 (6.5e41.5)
ppb, respectively, and the difference was not statistically
significant (PZ 0.292). Obese and non-obese subjects were
not significantly different regarding exhaled nitric oxide
concentration before and after sleep (P Z 0.256 and
P Z 0.567, respectively); but FENO was significantly
increased after sleep in obese patients (PZ 0.002), but not
in non-obese ones (P Z 0.649). FENO changes, before and
after sleep, were not significantly correlated with poly-
somnography parameters. Fig. 1 compares the mean
exhaled nitric oxide in three groups of subjects (Normal,
Obese OSA, Non-obese OSA).
Discussion
In this study, FENO was not significantly increased after
sleep among normal and OSA patients. The increase in
exhaled NO after sleep was significant in obese OSA pa-
tients but not in non-obese ones. Changes of FENO before
and after sleep were not significantly correlated with pol-
ysomnography parameters.
As we know, Obesity is associated with systemic oxida-
tive stress and such comorbid conditions as hypertension,
hyperlipidemia, insulin resistance and OSA; each of these
conditions can also increase the oxidative stress and sys-
tematic inflammation [9,15]. Several studies on the asso-
ciation between FENO (as an inflammatory index) and BMI
have reached to controversial results. Maniscalco et al.
found that FENO level is significantly lower in patients with
severe obesity than normo-weighted healthy controls which
was decreased after weight reduction [16].
But two other studies conducted by Tsang et al. and de
Winter-de Groot et al., found a positive correlation be-
tween BMI and FENO [17,18]. In the current study we
couldn’t find a significant difference in baseline FENO be-
tween obese and non-obese subjects.
Also frequent desaturations in OSA patients may lead to
systemic inflammation, and local trauma due to frequentopulation.
Non-obese OSA
n Z 16
Obese OSA
n Z 31
50.7  13.4 50.1  13.4
27.4  1.9a 35.4  3.9
38.8  3.1a 44.5  3.2
99.1  10.4a 117.4  11.0
3.4  1.2 3.5  0.9
2.8  1.0 2.8  0.8
84.4  6.7 81.8  8.7
3.2  0.9 3.1  1.3
Table 2 Polysomnographic and exhaled nitric oxide results.
Variable, unit Normal
n Z 7
Non-obese OSA
n Z 16
Obese OSA
n Z 31
Hypoxia, % 14.7  37.5 18.1  27.0 44.7  35.7
Desaturations, events 4.5  9.9 104.6  87.4 161.1  114.2
AHI,a events h1 3.0 (1.4e4.9) 40.1 (5.6e120.5) 39.5 (8.5e73.1)
Pre-sleep NO,a ppb 22.1 (5.0e58.0) 15.8 (2.0e31.0) 14.1 (3.0e31.0)
Post-sleep NO,a ppb 11.8 (1.0e30.0) 20.3 (5.0e45.0) 19.8* (9.0e44.0)
Data are presented as mean  SD.
AHI: apnea hypopnea index, events h1: events divided by hours, Hypoxia: percent of total sleep with O2 saturation <90%, Desaturation:
number of O2 saturation falling <90%, ppb: part per billion, *: P < 0.05 vs pre sleep NO.
a Non-parametric presented as mean (10e90 percentiles).
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There are several studies on non-invasive methods of
assessment of airway inflammation in patients with apnea.
One of the first ones was conducted by Olopade et al. They
found a significant increase in oral and nasal NO after sleep
in patients with moderate to severe apnea and concluded
that exhaled NO can be considered as a marker of upper
airway inflammation in patients with obstructive apnea [5].
The study conducted by Agusti et al. failed to show a
significant difference in exhaled NO between OSA patients
and normal subjects. They also couldn’t find a significant
relationship between the concentration of exhaled NO and
AHI, BMI and O2 saturation. These studies have not assessed
obesity as an independent factor leading to airway
inflammation [6]. Two studies have assessed the effect of
obesity on exhaled NO. Depalo et al. assessed exhaled NO
and inducible nitric oxide synthase expression (iNOS) in
inflammatory cells of sputum and found that both markers
were significantly higher in obese and non-obese patients
with apnea. They found as well a positive relationship be-
tween exhaled NO and iNOS with AHI [19]. In another study
exhaled NO and inflammatory cell profile in the induced
sputum and pH in the exhaled breath condensate were
compared between obese patients, with and without OSAFigure 1 Comparison of the mean exhaledand normal subjects. PH was significantly lower in obese
patients. NO concentration and the percent of neutrophils
were also higher than normal subjects, but the study didn’t
show a significant difference between obese patients with
and without apnea regarding inflammatory markers [20].
None of these studies have assessed non-obese patients
with apnea.
In the current study, the increased exhaled NO after
sleep in obese patients with OSA and no significant increase
in non-obese subjects with OSA and normal subjects, pro-
poses that the obesity is an independent risk factor in the
development of airway inflammation in patients with OSA.
The limitations of this study were the small number of
normal subjects and absence of a control group of obese
non-OSA subjects. Future studies are recommended for
longitudinal assessment of changes in exhaled NO among
patients with apnea and after continuous positive airway
pressure (CPAP) use especially in obese patients.Conclusion
Increased exhaled nitric oxide in obese patient with apnea
not in non-obese ones proposed that the obesity is a markernitric oxide in three groups of subjects.
Obstructive sleep apnea and obesity 1233of airways inflammation in patients with obstructive sleep
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